Deer Management Co. LLC - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Deer Management Co. LLC ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,188,493
+2.4%
1,245,5050.0%0.39%
+38.9%
Q2 2023$3,113,763
+19.0%
1,245,5050.0%0.28%
+17.2%
Q1 2023$2,615,561
+35.5%
1,245,5050.0%0.24%
+34.3%
Q4 2022$1,930,533
-49.2%
1,245,5050.0%0.18%
-33.1%
Q3 2022$3,799,000
-3.0%
1,245,5050.0%0.27%
+5.1%
Q2 2022$3,917,000
+12.3%
1,245,5050.0%0.25%
+110.8%
Q1 2022$3,487,000
-37.8%
1,245,5050.0%0.12%
-16.7%
Q4 2021$5,605,0001,245,5050.14%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders